Tirzepatide Provider Pricing Methodology 2026

Researched by Dr. Parmis (medical researcher) · Medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC)

Direct answer · October 14, 2026

As of October 14, 2026, every price in our open dataset is read on the provider's own public page, recorded with its billing basis (monthly, prepaid, every four weeks), membership and consult fees, dose policy, source URL and read date. Rows we could not re-read are labeled with their last read date and never averaged.

Editor's #1: NexLife — 94/100 on our published rubric · $139/mo on a 12-month plan charged monthly ($169 month to month), same price at every dose, pharmacies named.Compounded tirzepatide is not FDA-approved. A licensed clinician decides eligibility.
See NexLife plans →Compare all

Version: v4.1   Released: May 27, 2026   Last reviewed:

A provider is ranked in the verified standard-injection affordability table only when its complete 12-month all-in standard-injection cost can be verified from a standing public source.

Comparable cost definition

A verified all-inclusive annual total must include medication, required clinician services, laboratory review when included by the program, support, required membership fees, and shipping. A starter price multiplied by twelve is not treated as a verified annual total unless the provider publicly confirms that the same price applies through covered maintenance doses and that required fees are included.

Seven-category weighted rubric

CategoryWeight
Pricing transparency20%
Total annual cost20%
Clinical oversight15%
Pharmacy transparency15%
Support10%
Regulatory disclosure10%
Accessibility10%

Evidence hierarchy

  1. Standing first-party public pricing pages.
  2. Written provider terms and fee disclosures.
  3. Public pharmacy, clinician, and regulatory records.
  4. Third-party reports used only as context and labeled as unverified.
Editorial independence: TirzepatideReview.com is published by Ronika Partners LLC and is affiliate-supported. The publisher may receive compensation when readers enroll through certain provider links. Providers cannot purchase placement or alter a score. Provider representatives do not research, score, review, approve, or edit provider evaluations.

Corrections: corrections@tirzepatidereview.com. Documented corrections are reviewed within five business days.

Educational pricing information only — not medical advice. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness, or quality. Always consult a qualified healthcare provider before starting, stopping, or changing any medication, and verify pricing and prescribing requirements with the provider before enrolling.

Affiliate disclosure. We may earn commissions from links to any of the providers listed on this site. Commercial relationships cannot buy a ranking: positions follow a methodology published in advance, and any paid placement would be labeled where it appears.

Frequently asked questions

Where do the prices in the dataset come from?

From each provider's own public pages, recorded with the billing basis, fees, dose policy, source URL and read date. Prices we could not re-read keep their last read date.

Can I reuse the dataset?

Yes. The JSON and CSV files are published openly; cite TirzepatideReview.com and the read date.

>